Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2266 AL 2280

Association of Relative Brain Hyperperfusion Independent of Dopamine Depletion With Motor Dysfunction in Patients With Parkinson Disease

Yoo HS, Lee YG, Sohn YH, Yun M, Cha J, Lee PH.

Neurology. 2025 Mar 25;104(6):e213392. doi: 10.1212/WNL.0000000000213392. Epub 2025 Feb 17.

Does drug repurposing bridge the gaps in management of Parkinson's disease? Unravelling the facts and fallacies

Bashir B, Vishwas S, Gupta G, Paudel KR, Dureja H, Kumar P, Cho H, Sugandhi VV, Kumbhar PS, Disouza J, Dhanasekaran M, Goh BH, Gulati M, Dua K, Singh SK.

Ageing Res Rev. 2025 Mar;105:102693. doi: 10.1016/j.arr.2025.102693. Epub 2025 Feb 15.

[Research progress of acupuncture regulating enteric nervous system in Parkinson's disease]

Xu K, Wang S, Bai Y, Wang YL, Li Y, Zhang CG, Shi Y, Wang TJ, Zhang YK.

Zhen Ci Yan Jiu. 2025 Jan 25;50(1):110-115. doi: 10.13702/j.1000-0607.20230775.

Molecular pathways: the quest for effective MAO-B inhibitors in neurodegenerative therapy

Oyovwi MO, Udi OA, Atere AD, Joseph GU, Ogbutor UG.

Mol Biol Rep. 2025 Feb 17;52(1):240. doi: 10.1007/s11033-025-10349-x.

Parkinson disease pathology can originate in the kidney

Kiani L.

Nat Rev Neurol. 2025 Mar;21(3):125. doi: 10.1038/s41582-025-01066-x.

Tai Chi improves balance, mobility and gait function of the lower limbs in patients with Parkinson's disease: a systematic review and meta-analysis

Lou L, Xiang C, Hu Y, Yang J.

Eur J Med Res. 2025 Feb 17;30(1):107. doi: 10.1186/s40001-024-02151-5.

Parkinson's disease and glucose metabolism impairment

Chen L, Wang C, Qin L, Zhang H.

Transl Neurodegener. 2025 Feb 17;14(1):10. doi: 10.1186/s40035-025-00467-8.

To Trust or Not to Trust? ICD-Coded Diagnosis of Parkinson's Disease

Lo RY.

Mov Disord. 2025 Feb;40(2):181-183. doi: 10.1002/mds.30105.

Pro-Oxidative and Inflammatory Actions of Extracellular Hemoglobin and Heme: Molecular Events and Implications for Alzheimer's and Parkinson Disease

Campomayor NB, Kim HJ, Kim M.

Biomol Ther (Seoul). 2025 Mar 1;33(2):235-248. doi: 10.4062/biomolther.2024.224. Epub 2025 Feb 18.

Economic evaluation of mHealth solutions in PD: where do we stand?

Kanellos FS, Petkou E, Konitsiotis S, Simos YV, Lakkas L, Peschos D, Tsamis KI.

Neurodegener Dis Manag. 2025 Feb;15(1):5-8. doi: 10.1080/17582024.2025.2467020. Epub 2025 Feb 18.

IRMA: Machine learning-based harmonization of 18 F-FDG PET brain scans in multi-center studies

Lövdal SS, van Veen R, Carli G, Renken RJ, Shiner T, Bregman N, Orad R, Arnaldi D, Orso B, Morbelli S, Mattioli P, Leenders KL, Dierckx R, Meles SK, Biehl M; for the Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2025 Jul;52(8):2941-2958. doi: 10.1007/s00259-025-07114-4. Epub 2025 Feb 18.

Mechanistic role of proteins and peptides in Management of Neurodegenerative Disorders

Awasthi S, Tiwari PC, Awasthi S, Dwivedi A, Srivastava S.

Neuropeptides. 2025 Mar;110:102505. doi: 10.1016/j.npep.2025.102505. Epub 2025 Feb 13.

Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications

Hatzimanolis O, Sykes AM, Cristino AS.

Mol Psychiatry. 2025 Apr;30(4):1652-1675. doi: 10.1038/s41380-025-02925-1. Epub 2025 Feb 17.

Imaging Alpha-synuclein with Novel 5H-Imidazo[1,5-b][1,2,4]triazole Radioligands for the Diagnosis of Parkinson's Disease

Song Z, Liang SH.

ACS Med Chem Lett. 2025 Jan 6;16(2):182-183. doi: 10.1021/acsmedchemlett.4c00607. eCollection 2025 Feb 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias